European and international scientific bodies, such as the European Medicines Agency [Note for guidance on minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products (EMA/410/01 rev.3) (OJ C 73, 5.3.2011, p. 1).], the European Food Safety Agency [http://www.efsa.europa.eu/en/topics/topic/bse.htm], the former Scientific Steering Committee [http://ec.europa.eu/food/fs/bse/scientific_advice08_en.print.html] and the former Scientific Committee on Medicinal Products and Medical Devices [See http://ec.europa.eu/health/scientific_committees/emerging/opinions/scmpmd/index_en.htm], adopted several opinions on specified risk materials and on minimising the risk of transmitting animal spongiform encephalopathy agents which are of relevance to the safety of medical devices.
Recital 7, Commission Regulation (EU) No 722/2012 of 8 August 2012 concerning particular requiremen…
In forcesince 8 Aug 2012